Medtronic plc
US ˙ NYSE ˙ IE00BTB1Y115

SecurityMDT / Medtronic plc
InstitutionMarex Group plc
Latest Disclosed Ownership5,840 shares
Latest Disclosed Value $ 506,036
Marex Group plc reports 39.95% increase in ownership of MDT / Medtronic plc

On May 13, 2026 - Marex Group plc filed a 13F-HR form disclosing ownership of 5,840 shares of Medtronic plc (US:MDT) valued at $506,036 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 4,173 shares of Medtronic plc. This represents a change in shares of 39.95% during the quarter. The current value of the position is $476,953 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F MEDTRONIC SHS G5960L103 5,840 1,667 39.95 506 26.50 0.0021
2026-02-12 2025-12-31 13F MEDTRONIC SHS G5960L103 4,173 -83,279 -95.23 401 -95.20 0.0025
2025-11-14 2025-09-30 13F MEDTRONIC SHS G5960L103 87,452 83,819 2,307.16 8,329 2,535.44 0.0589
2025-08-19 2025-06-30 13F MEDTRONIC SHS G5960L103 3,633 -5,388 -59.73 317 -60.99 0.0027
2026-04-02 2025-03-31 13F MEDTRONIC SHS G5960L103 9,021 6,032 201.81 811 240.34 0.0155
2026-04-02 2024-12-31 13F MEDTRONIC SHS G5960L103 2,989 -62 -2.03 239 -13.14 0.0041
2026-04-07 2024-09-30 13F MEDTRONIC SHS G5960L103 3,051 -75,193 -96.10 275 -95.55 0.0063
2026-04-02 2024-06-30 13F MEDTRONIC SHS G5960L103 78,244 73,823 1,669.83 6,159 1,499.48 0.1654
2026-04-02 2024-03-31 13F MEDTRONIC SHS G5960L103 4,421 480 12.18 385 18.83 0.0125
2026-04-02 2023-12-31 13F MEDTRONIC SHS G5960L103 3,941 398 11.23 325 16.97 0.0128
2026-04-02 2023-09-30 13F MEDTRONIC SHS G5960L103 3,543 965 37.43 278 22.03 0.0392
2026-04-02 2023-06-30 13F MEDTRONIC SHS G5960L103 2,578 -568 -18.05 227 -10.28 0.0410
2026-04-02 2023-03-31 13F MEDTRONIC SHS G5960L103 3,146 3,146 254 0.0336
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.